The U.S. Food and Drug Administration (FDA) has approved a new generic version of the drug gabapentin. This drug is used to treat two main conditions. The first is a specific type of nerve pain that can follow a shingles infection, called postherpetic neuralgia. The second is as an add-on treatment for certain types of seizures in people with epilepsy.
This approval is for a generic capsule, which is often a lower-cost version of a brand-name drug. It is approved for adults with nerve pain and for adults and children aged 3 and older with epilepsy. The approval gives doctors and patients another treatment option that follows the same established dosing plans.
For patients, this news means there may be increased access to this medication. However, it is very important to understand that this is not a new drug, but a new version of an existing one. The approval does not change how the drug works or its safety profile.
The most important step for anyone currently taking gabapentin or considering it is to speak with their healthcare provider. Only a doctor who knows your full medical history can determine if this specific generic version is right for your individual treatment plan.